Close Menu

NEW YORK — Pharmacogenetic test results might not lead patients to avoid certain helpful treatments as feared, a new clinical trial focusing on statins has found.

Pharmacogenetic testing enables patients to learn whether they harbor any genetic variants that could affect their response to particular drugs, with an eye toward selecting more effective therapies. But there are also concerns that positive test results could lead patients to avoid drugs for their possible adverse effects and shy away from treatments from which they may still benefit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.